Aurora Financial Advisors’s Pfizer PFE Stock Holding History

Aurora Financial Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$2M	Buy	+58,189	New	+$1.98M	1.43%	9

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Aurora Financial Advisors's PFE Position: Q4 2017 in Review

Aurora Financial Advisors opened a new position in Pfizer (PFE) in Q4 2017: 58,189 shares worth $2M. The stake represents 1.43% of the portfolio and ranks #9 among its holdings.

2,244 funds tracked by Wall St. Rank hold PFE as of Q4 2017.

Aurora Financial Advisors held 58,189 shares of Pfizer worth $2M as of Q4 2017.
Pfizer was a new Aurora Financial Advisors position in Q4 2017.
Pfizer made up 1.43% of Aurora Financial Advisors's portfolio in Q4 2017, its #9 holding.
2,244 funds tracked by Wall St. Rank held Pfizer as of Q4 2017.

Based on Aurora Financial Advisors's 13F filing for Q4 2017, filed 16 Mar 2018.